Capricorn Partners is thrilled to announce the first closing at €51 million for its newest venture capital fund, Capricorn Healthtech Fund II, investing in healthcare transformers in digital health & medtech. This fund marks a significant milestone in our ongoing commitment to advancing personalized healthcare and promoting value-based health initiatives across Europe.
Investing across Europe from a Benelux base
The Capricorn Healthtech Fund II will operate as a pan-European fund, targeting investment in 10-15 companies in the late seed to Series B stages. With initial investment tickets between 1 and 5 million euros, the fund will invest in traditional medical devices as well as novel health software platforms and applications. While our investment scope extends across Europe, we maintain a steadfast commitment to investing in our home-base, the Benelux region.
Welcoming New and Existing Limited Partners
We are delighted to welcome both our existing Limited Partners (LPs) and new investors into the Capricorn Healthtech Fund II. Among the new LPs joining us are Invest-NL and Sensinnovat, “Invest-NL is committed to driving the essential transition in healthcare by investing in innovations that prevent, replace or shift expensive care. Capricorn Partners brings the expertise needed to guide this process effectively, making them a valuable partner within our ecosystem.” says Ulrike Kostense, Lead Indirect Investments. Also Geert Reynders, Chief Investment Officer at Sensinnovat comments: “We are excited to partner with Capricorn Healthtech Fund II, as it aligns with our commitment to investing in healthtech solutions that improve lives and strengthen healthcare systems worldwide”. They join our existing cornerstone investors Quest for Growth, AG Insurance/Ageas, PMV, finance&invest.brussels and the KU Leuven Research & Development. “Our investment in the Capricorn Healthtech Fund II aligns perfectly with the strategy of Ageas and AG Insurance to invest in the real economy and to follow the latest developments in health and technology, and furthermore illustrates the longstanding partnership with Capricorn Partners” according to Gilke Eeckhoudt, Chief Development & Sustainability Officer Ageas and Wim Vermeir, Chief Investment Officer AG Insurance.
In addition, we welcome also COI, acting as impact investor to promote digital innovation in Flanders.
Looking Ahead
The first closing of Capricorn Healthtech Fund II is just the beginning – our goal is to establish a €100+ million fund and we continue to engage with additional investors while building our portfolio with healthcare transformers.
For more information about Capricorn Healthtech Fund II and our investment strategy, please visit our website or contact our team.
For further reading, please go to Capricorn’s website.